Carnosic acid-rich rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and improves cholesterol levels and glycaemia in mice on a high-fat diet

British Journal of Nutrition

Volumn 106, Issue 8, 2011, Pages 1182-1189

  Ibarra, Alvin ^a   Cases, Julien ^b   Roller, Marc ^b   Chiralt Boix, Amparo ^c   Coussaert, Aurélie ^d   Ripoll, Christophe ^d  

^a Naturex Inc   (United States)

^b Givaudan SA   (Switzerland)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^d Naturalpha SAS   (France)

Author keywords

Carnosic acid; Pancreatic lipase; PPAR ; Rosmarinus officinalis L.

Indexed keywords

CARNOSIC ACID; CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; ROSMARINUS OFFICINALIS EXTRACT; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; EPIDIDYMIS FAT; EPIDIDYMIS FAT WEIGHT; EXPERIMENTAL MODEL; FATTY ACID BLOOD LEVEL; FECAL FAT EXCRETION; FECES ANALYSIS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; INSULIN BLOOD LEVEL; JUVENILE ANIMAL; LIPID DIET; LIVER WEIGHT; LOW FAT DIET; MALE; MOUSE; NONHUMAN; PLANT LEAF; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIET, HIGH-FAT; DITERPENES, ABIETANE; EATING; MALE; METABOLIC DISEASES; MICE; MICE, INBRED C3H; ORGAN SIZE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; ROSMARINUS; WEIGHT GAIN;

ANIMALIA; MUS; ROSMARINUS OFFICINALIS;

EID: 80054923618     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511001620     Document Type: Article

References (34)

1. Baena Diez JM, del Val Garcia JL, Tomas PJ, et al. (2005) Cardiovascular disease epidemiology and risk factors in primary care. Rev Esp Cardiol 58, 367-373. (Pubitemid 40724221)
2. Anderson JW & Konz EC (2001) Obesity and disease management: effects of weight loss on comorbid conditions. Obes Res 9, Suppl. 4, 326S-334S.
3. Czernichow S, Mennen L, Bertrais S, et al. (2002) Relationships between changes in weight and changes in cardiovascular risk factors in middle-aged French subjects: effect of dieting. Int J Obes Relat Metab Disord 26, 1138-1143.
4. Unwin N, Gan D & Whiting D (2010) The IDF diabetes atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract 87, 2-3.
5. Furukawa S, Fujita T, Shimabukuro M, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752-1761. (Pubitemid 40385531)
6. Gregor MF & Hotamisligil GS (2010) Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415-445.
7. Jouad H, Haloui M, Rhiouani H, et al. (2001) Ethnobotanical survey of medicinal plants used for the treatment of diabetes, cardiac and renal diseases in the North centre region of Morocco (Fez-Boulemane). J Ethnopharmacol 77, 175-182. (Pubitemid 32780513)
8. Raskin I, Ribnicky DM, Komarnytsky S, et al. (2002) Plants and human health in the twenty-first century. Trends Biotechnol 20, 522-531. (Pubitemid 35356407)
9. Balunas MJ & Kinghorn AD (2005) Drug discovery from medicinal plants. Life Sci 78, 431-441. (Pubitemid 41653493)
10. Ye J (2008) Botanical treatments for diabetes and obesity. Endocr Metab Immune Disord Drug Targets 8, 77.
11. Panda H (2009) Cultivation of Rosmarinus officinalis. In Aromatic Plants Cultivation, Processing and Uses, pp. 22-28 (National Institute of Industrial Research, editor). New Delhi: Asia Pacific Business Press, Inc.
12. Etter SC (2004) Rosmarinus officinalis as an antioxidant. J Herbs Spices Med Plants 11, 121-159. (Pubitemid 40663184)
13. Aguilar F, Autrup H, Barlow S, et al. (2008) Use of rosemary exracts as a food additive. Scientific opinion of the panel on food additives, flavourings, processing aids and materials in contact with food. EFSA J 721, 1-29.
14. Al-Sereiti MR, Abu-Amer KM & Sen P (1999) Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 37, 124-130. (Pubitemid 29103965)
15. Ibarra A, Cases J, Bily A, et al. (2010) Importance of extract standardization and in vitro/ex vivo assay selection for the evaluation of antioxidant activity of botanicals: a case study on three Rosmarinus officinalis L. extracts. J Med Food 13, 1167-1175.
16. Posadas SJ, Caz V, Largo C, et al. (2009) Protective effect of supercritical fluid rosemary extract, Rosmarinus officinalis, on antioxidants of major organs of aged rats. Exp Gerontol 44, 383-389.
17. Yu YM, Lin CH, Chan HC, et al. (2009) Carnosic acid reduces cytokine-induced adhesion molecules expression and monocyte adhesion to endothelial cells. Eur J Nutr 48, 101-106.
18. Mengoni ES, Vichera G, Rigano LA, et al. (2010) Suppression of COX-2, IL-1beta and TNF-alpha expression and leukocyte infiltration in inflamed skin by bioactive compounds from Rosmarinus officinalis L. Fitoterapia 82, 414-421.
19. Ninomiya K, Matsuda H, Shimoda H, et al. (2004) Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorg Med Chem Lett 14, 1943-1946. (Pubitemid 38410869)
20. Rau O, Wurglics M, Paulke A, et al. (2006) Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Med 72, 881-887. (Pubitemid 44378949)
21. Takahashi T, Tabuchi T, Tamaki Y, et al. (2009) Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism. Biochem Biophys Res Commun 382, 549-554.
22. Harach T, Aprikian O, Monnard I, et al. (2010) Rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet. Planta Med 76, 566-571.
23. Wang T, Takikawa Y, Satoh T, et al. (2011) Carnosic acid prevents obesity and hepatic steatosis in ob/ob mice. Hepatol Res 41, 87-92.
24. Erenmemisoglu A, Saraymen R & Ustun S (1997) Effect of a Rosmarinus officinalis leave extract on plasma glucose levels in normoglycaemic and diabetic mice. Pharmazie 52, 645-646. (Pubitemid 27355165)
25. Folch J, Lees M & Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
26. Surwit RS, FeinglosMN, Rodin J, et al. (1995) Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44, 645-651.
27. Black BL, Croom J, Eisen EJ, et al. (1998) Differential effects of fat and sucrose on body composition in A/J and C57BL/6 mice. Metabolism 47, 1354-1359. (Pubitemid 28523467)
28. Micic D, Ivkovic-Lazar T, Dragojevic R, et al. (1999) Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia. Med Pregl 52, 323-333.
29. Muls E, Kolanowski J, Scheen A, et al. (2001) The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebocontrolled, multicentre study. Int J Obes Relat Metab Disord 25, 1713-1721. (Pubitemid 33052084)
30. Erdmann J, Lippl F, Klose G, et al. (2004) Cholesterol lowering effect of dietary weight loss and orlistat treatmentefficacy and limitations. Aliment Pharmacol Ther 19, 1173-1179. (Pubitemid 38746260)
31. Han LK, Zheng YN, Yoshikawa M, et al. (2005) Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complement Altern Med 5, 9.
32. Sheng L, Qian Z, Zheng S, et al. (2006) Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase. Eur J Pharmacol 543, 116-122. (Pubitemid 44092692)
33. Young SC & Hui DY (1999) Pancreatic lipase/colipasemediated triacylglycerol hydrolysis is required for cholesterol transport from lipid emulsions to intestinal cells. Biochem J 339, 615-620. (Pubitemid 29243525)
34. Bakirel T, Bakirel U, Keles OU, et al. (2008) In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. J Ethnopharmacol 116, 64-73.